José Carlos Gasca

Dr. José Carlos Gasca

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
JGJosé Carlos Gasca
José Carlos Gasca
JCJesús Enrique Castrejón-Sánchez
Jesús Enrique Castrejón-Sánchez
MFMario Carrasco Flores
Mario Carrasco Flores
Enzo Vasquez JimenezEnzo Vasquez Jimenez
Enzo Vasquez Jimenez
PCPaulina Carpinteyro-Espin
Paulina Carpinteyro-Espin
PCPaula Costa-Urrutia
Paula Costa-Urrutia
Background/Objectives: Acute liver failure (ALF) is a life-threatening condition with high mortality in nontransplant candidates. Therapeutic plasma exchange (TPE) has emerged as a promising intervention for removing inflammatory mediators and toxic metabolites. In Latin America, data on the efficacy of TPE in ALF patients are limited. This real-world study aimed to compare 30-day survival outcomes between patients receiving standard medical treatment (SMT) and those receiving SMT plus TPE. Methods: We analyzed 25 ALF patients admitted to the tertiary intensive care unit (ICU) of Hospital Juárez of Mexico City, Mexico, from 2018 to 2024. Patients received either standard medical treatment (SMT group, n = 12) or SMT with TPE (TPE group, n = 13), including high-volume TPE (n = 8) and standard-volume TPE (n = 5). Survival analysis was performed via Kaplan–Meier estimates, and binomial regression analysis was run to estimate the mortality probability stratified by the hepatic encephalopathy grade. Results: At 30 days, survival was significantly greater in the TPE group (92%) than in the SMT group (50%) (p = 0.02). The greatest survival benefit was observed in patients with Grade 4 encephalopathy. The ICU stay was longer in the TPE group, reflecting the complexity of ALF management. Conclusions: TPE significantly improves 30-day survival in ALF patients compared with SMT alone, supporting its role as an adjunct therapy. Further studies are needed to refine patient selection and optimize treatment protocols.

3 June 2026 in Critical Care
Verified
Journal Article
Open access
JGJosé Carlos Gasca
José Carlos Gasca
OFOsvaldo Alexis Marché Fernández
Osvaldo Alexis Marché Fernández
JSJesús Enrique Castrejón Sánchez
Jesús Enrique Castrejón Sánchez

28 September 2025 in Diseases
Verified
Journal Article
Open access
PDF file
GLGUSTAVO ESTEBAN LUGO-ZAMUDIO
GUSTAVO ESTEBAN LUGO-ZAMUDIO
OSOscar Sosa-Hernández
Oscar Sosa-Hernández
BLBriceida LOPEZ López-Martínez
Briceida LOPEZ López-Martínez
Clemente Cruz-CruzClemente Cruz-Cruz
Clemente Cruz-Cruz
EDEMILIO MARIANO MANUEL DURAN
EMILIO MARIANO MANUEL DURAN
Juan Manuel Bello-LópezJuan Manuel Bello-López
Juan Manuel Bello-López
In Mexico, syphilis and tuberculosis are infectious diseases subject to mandatory and immediate epidemiological surveillance, both with special systems that allow nominal follow-up for either variant. Surveillance uses the operational definitions of probable and confirmed cases established in the manual for epidemiological surveillance issued by the General Directorate of Epidemiology of the Ministry of Health. However, both diseases, mainly in the chronic state, present challenges because of their ability to mimic autoimmune disorders. This review explores the phenomenon of clinical and immunological mimicry in secondary and tertiary syphilis, as well as in extrapulmonary tuberculosis, and analyzes its implications for the accuracy of case reporting at the national level. Evidence shows that both infections can present systemic inflammatory features, such as elevated acute phase reactants, positive autoantibodies, and alterations in cerebrospinal fluid that resemble autoimmune profiles. These overlaps can lead to misdiagnosis, inappropriate immunosuppressive treatment and misclassification of confirmed cases within the Mexican surveillance system. Surveillance of these conditions is robust; however, current operational definitions have weaknesses, particularly when atypical or autoimmune conditions are present, as they only focus on cases with the highest prevalence or public health impact. This manuscript proposes the integration of differential diagnostic algorithms and expanded laboratory criteria, including autoimmune markers and molecular tests, into surveillance protocols. Although individual efforts exist in health institutions, in our country, the absence of autoimmune diseases in the national register of obligatory notification stands out, contrasting with surveillance models in other countries, where autoimmune diseases are tracked systematically. To improve diagnostic accuracy and reporting, surveillance systems should incorporate a syndromic and etiological approach, recognizing infectious autoimmune mimicry as a factor in the final recording of confirmed cases to avoid epidemiological silence.

19 August 2026 in CHEST Critical Care
Verified
Journal Article
Open access
JGJosé Carlos Gasca
José Carlos Gasca
EREduardo Rodríguez-Puente
Eduardo Rodríguez-Puente
MCMario Arturo Carrasco-Flores
Mario Arturo Carrasco-Flores
OMOsvaldo Alexis Marché-Fernández
Osvaldo Alexis Marché-Fernández
JMJuan Ángel Morales-Ferrer
Juan Ángel Morales-Ferrer
EGEduardo Alberto González-Escudero
Eduardo Alberto González-Escudero

10 June 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
JGJosé Carlos Gasca
José Carlos Gasca
JCJesús Enrique Castrejón-Sánchez
Jesús Enrique Castrejón-Sánchez
MFMario Carrasco Flores
Mario Carrasco Flores
Enzo Vasquez JimenezEnzo Vasquez Jimenez
Enzo Vasquez Jimenez
PCPaulina Carpinteyro-Espin
Paulina Carpinteyro-Espin
PCPaula Costa-Urrutia
Paula Costa-Urrutia
Background/Objectives: Acute liver failure (ALF) is a life-threatening condition with high mortality in nontransplant candidates. Therapeutic plasma exchange (TPE) has emerged as a promising intervention for removing inflammatory mediators and toxic metabolites. In Latin America, data on the efficacy of TPE in ALF patients is limited. This real-world study aimed to compare 30-day survival outcomes between patients receiving standard medical treatment (SMT) and those receiving SMT plus TPE. Methods: We analyzed 25 ALF patients admitted to the tertiary intensive care unit (ICU) of Hospital Juárez of Mexico City, Mexico, from 2018–2024. Patients received either standard medical treatment (SMT group, n=12) or SMT with TPE (TPE group, n=13), including high-volume TPE (n=8) and standard-volume TPE (n=5). Survival analysis was performed via Kaplan‒Meier estimates, and binomial regression analysis was run to estimate the mortality probability stratified by the hepatic encephalopathy grade. Results: At 30 days, survival was significantly greater in the TPE group (92%) than in the SMT group (50%) (p = 0.02). The greatest survival benefit was observed in patients with Grade 4 encephalopathy. The ICU stay was longer in the TPE group, reflecting the complexity of ALF management. Conclusion: TPE significantly improves 30-day survival in ALF patients compared with SMT alone, supporting its role as an adjunct therapy. Further studies are needed to refine patient selection and optimize treatment protocols.

1 July 2021 in Medicina Clínica Práctica
Verified
Journal Article
Open access
JGJosé Carlos Gasca
José Carlos Gasca
CYChristian D. Yañez-Velez
Christian D. Yañez-Velez
JCJorge A. Castañón-González
Jorge A. Castañón-González